Reports for PHARMA STULLN INC.
Company Name PHARMA STULLN INC. |
||
|---|---|---|
Totals |
||
Shortage reports |
6 |
|
| Actual shortage: | 1 (17%) | |
| Anticipated shortage: | 1 (17%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 4 (67%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
1 (17%) |
|
Overdue reports |
1 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATROPINE | 1% | SOLUTION SOLUTION | Actual shortage | 2020-10-01 | 2023-10-14 | 125517 |
| BALANCED SALT SOLUTION | 0.48MG 1.7MG 6.4MG 3.9MG 0.75MG 0.3MG | SOLUTION | Anticipated shortage | 2025-08-15 | 2025-08-15 | 257204 |
| DEXAMETHASONE | 0.1% | SOLUTION SOLUTION | Resolved | 2023-02-13 | 2023-07-07 | 184454 |
| DEXAMETHASONE | 0.1% | SOLUTION SOLUTION | Resolved | 2025-02-25 | 2025-04-08 | 251206 |
| DICLOFENAC | 0.1% | SOLUTION | Resolved | 2020-11-26 | 2021-01-02 | 128917 |
| DICLOFENAC | 0.1% | SOLUTION | Resolved | 2023-05-17 | 2023-09-14 | 192637 |
Showing 1 to 6 of 6
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0